LBX Pharmacy Chain Joint Stock Company (SHA:603883)
China flag China · Delayed Price · Currency is CNY
14.48
-0.12 (-0.82%)
Oct 29, 2026, 2:14 PM CST

SHA:603883 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-22,23722,35822,43720,17615,696
Revenue Growth
--0.54%-0.36%11.21%28.54%12.38%
Gross Profit
-7,1737,4127,2806,4255,037
Operating Income
-1,0911,1651,4691,3711,027
Net Income
-381.85519.06929.02784.96669.24
Earnings Per Share
0.610.500.681.231.050.95
EPS Growth
11.47%-26.47%-44.71%17.57%10.57%5.20%

Revenue by Segment

Fiscal Year
FY 2025
Period EndingDec '25
Pharmaceutical Retail
19,115
Others
442.02
Wholesale Division
12,311
Inter Segment Offset
-9,632
Total
22,237

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2,0922,3802,4162,0082,4251,419
Total Debt
3,7664,5645,7815,0335,4566,021
Net Cash (Debt)
-1,673-2,184-3,365-3,025-3,031-4,602
Net Cash Growth
------
Net Cash Per Share
-2.18-2.86-4.41-4.00-4.04-6.51

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
3,1903,1432,0262,7302,3142,298
Capital Expenditures
-165.1-253.44-507.5-620.87-308.44-478.61
Free Cash Flow
3,0252,8891,5192,1092,0061,820
Free Cash Flow Growth
19.73%90.21%-27.98%5.14%10.23%72.78%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
32.02%32.26%33.15%32.45%31.84%32.09%
Operating Margin
-4.91%5.21%6.55%6.80%6.54%
Pretax Margin
-3.40%4.10%6.27%5.99%6.13%
Profit Margin
-1.72%2.32%4.14%3.89%4.26%
FCF Margin
-12.99%6.79%9.40%9.94%11.59%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.4100.4100.4110.5080.3850.296
Dividend Per Share Growth
159.09%-0.17%-19.11%32.01%30.02%42.83%
Dividend Yield
2.83%2.77%2.51%2.21%1.23%1.11%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
23.6529.4123.9818.8230.1629.97
Forward PE
18.1418.8613.8717.5731.5827.90
P/FCF Ratio
3.663.898.198.2911.8011.02
PS Ratio
0.490.510.560.781.171.28